{
  "paper_metadata": {
    "pmid": "36188564",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses mutations in the KCNH2 gene, specifically S620T, S641A, and S641T, and their effects on hERG channel function and drug interactions."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.1860C>T",
      "protein_notation": "p.Ser620Thr",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "abolished inactivation and significantly attenuated dofetilide block"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "abolished inactivation and significantly attenuated dofetilide block",
          "evidence_sentence": "Replacing S620 with threonine (S620T) has been shown to abolish inactivation and significantly attenuate dofetilide block of hERG."
        }
      ],
      "functional_data": {
        "summary": "The S620T mutation abolishes inactivation and affects drug binding.",
        "assays": [
          "in vitro studies",
          "functional assays"
        ]
      },
      "segregation_data": "not specified",
      "population_frequency": "not specified",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The mutation is associated with significant functional changes in the hERG channel.",
      "key_quotes": [
        "Replacing S620 with threonine (S620T) has been shown to abolish inactivation and significantly attenuate dofetilide block of hERG."
      ]
    },
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.1921C>T",
      "protein_notation": "p.Ser641Ala",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "strongly increases hERG channel inactivation and attenuates binding of E-4031"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "strongly increases hERG channel inactivation and attenuates binding of E-4031",
          "evidence_sentence": "The S641A mutation has been shown to strongly increase hERG channel inactivation and attenuate the binding of E-4031."
        }
      ],
      "functional_data": {
        "summary": "The S641A mutation enhances inactivation and alters drug binding.",
        "assays": [
          "in vitro studies",
          "functional assays"
        ]
      },
      "segregation_data": "not specified",
      "population_frequency": "not specified",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The mutation significantly affects the functional properties of the hERG channel.",
      "key_quotes": [
        "The S641A mutation has been shown to strongly increase hERG channel inactivation and attenuate the binding of E-4031."
      ]
    },
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.1921C>A",
      "protein_notation": "p.Ser641Thr",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "non-inactivating mutation"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "uncertain",
          "phenotype_details": "non-inactivating mutation",
          "evidence_sentence": "The S641T mutation suggested a potential molecular mechanism preventing F627 side chain from shifting into the ion conduction pathway during the proposed inactivation process."
        }
      ],
      "functional_data": {
        "summary": "The S641T mutation is associated with non-inactivating properties.",
        "assays": [
          "in vitro studies",
          "functional assays"
        ]
      },
      "segregation_data": "not specified",
      "population_frequency": "not specified",
      "evidence_level": "low",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The functional impact of this mutation is less clear compared to S620T and S641A.",
      "key_quotes": [
        "The S641T mutation suggested a potential molecular mechanism preventing F627 side chain from shifting into the ion conduction pathway during the proposed inactivation process."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant variants in KCNH2 were extracted successfully."
  }
}